全球癌症发病率不断增长，癌症已成为全球主要的公共问题。 36氪获悉，太盟投资集团（PAG）近日已完成对意大利新药研发企业NMS集团45%股权的收购，交易规模超14亿元。本次交易完成后，NMS集团将获得更为充沛的研发资金支持。 创立于1965年的NMS集团是一家知名 ...

经过四年的投后赋能加持，NMS集团已进入加速发展期。一村见证了NMS可喜的成绩，同时也帮助NMS集团建立起了与中国沟通与合作的桥梁。 2018年初，一村资本牵头组建中方联合并购方，完成对意大利老牌肿瘤研发机构NMS集团的控股型收购，该交易的总价值（包含 ...

意大利内尔维亚诺--(BUSINESS WIRE)--(美国商业资讯)--Nerviano Medical Sciences S.r.l. (NMS)是NMS集团下属成员公司，也是一家发现和开发癌症创新疗法的临床阶段公司。该公司今天宣布与Merck Healthcare KGaA签署了一项包含许可选择权的合作协议，以开发新一代高选择性和脑渗透 ...

Neuroleptic malignant syndrome (NMS) is a rare neurological condition associated with the use of antipsychotic medications. Autonomic dysfunction, or damage to the nerves that control involuntary ...

Neuroleptic malignant syndrome (NMS) is a rare reaction to antipsychotic drugs that are used to treat schizophrenia, bipolar disorder, and other mental health conditions. It affects the nervous system ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

LOS ANGELES, CA / ACCESS Newswire / May 12, 2025 / NMS Capital Group ("NMS") is proud to announce its inclusion in the Los Angeles Business Journal's 2024 list of Top Private Equity Firms, published ...